| Literature DB >> 36093229 |
Lynden G Nicely1, Ruturajsinh M Vala2, Dipti B Upadhyay2, Joaquina Nogales1, Celestine Chi3, Sourav Banerjee1, Hitendra M Patel2.
Abstract
We report a one-pot two-step synthesis of a bioactive 6-amino-2-pyridone-3,5-dicarbonitrile derivative using natural product catalysts betaine and guanidine carbonate. Anti-cancer bioactivity was observed in specific molecules within the library of 16 derivatives. Out of the compounds, 5o had the most potent anti-cancer activity against glioblastoma cells and was selected for further study. Compound 5o showed anti-cancer properties against liver, breast, lung cancers as well as primary patient-derived glioblastoma cell lines. Furthermore, 5o in combination with specific clinically relevant small molecule inhibitors induced enhanced cytotoxicity in glioblastoma cells. Through our current work, we establish a promising 6-amino-2-pyridone-3,5-dicarbonitrile based lead compound with anti-cancer activity either on its own or in combination with specific clinically relevant small molecule kinase and proteasome inhibitors. This journal is © The Royal Society of Chemistry.Entities:
Year: 2022 PMID: 36093229 PMCID: PMC9400646 DOI: 10.1039/d2ra03579k
Source DB: PubMed Journal: RSC Adv ISSN: 2046-2069 Impact factor: 4.036